After failing to raise enough money to stay open, Ohana Biosciences is closing its doors. Launched in January 2020 by Flagship Pioneering, Ohana was being dubbed a “first-in-category reproductive health company” focused on the industry’s first sperm biology platform. This was a major shift from the traditional approach of focusing on egg biology.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,